4//SEC Filing
Kalb Michael Wayne 4
Accession 0001209191-23-029076
CIK 0001445499other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:41 PM ET
Size
8.0 KB
Accession
0001209191-23-029076
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2023-05-10+175,000→ 175,000 totalExercise: $2.43Exp: 2033-05-10→ Common Stock (175,000 underlying) - Award
Restricted Stock Units (RSUs)
2023-05-10+47,500→ 47,500 totalExp: 2033-05-10→ Common Stock (47,500 underlying)
Footnotes (3)
- [F1]The option vests as to 25% of the total shares on May 10, 2024 and then 1/48th of the total shares vests on each monthly anniversary thereafter, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 100% of the total shares on May 31, 2024, subject to the reporting person's continuation of employment on such vesting date.
Documents
Issuer
IMPEL PHARMACEUTICALS INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001678248
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:41 PM ET
- Size
- 8.0 KB